BMDSys
Founded Year
2005Stage
Other Investors | AliveAbout BMDSys
BMDSys develops, produces, sells and services non-invasive, contact-free cardiac diagnostic imaging systems using extremely high sensitive magnetic sensors. It does not expose the patient to any X-Rays, magnetic field or any other kind
Missing: BMDSys's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: BMDSys's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
BMDSys Patents
BMDSys has filed 1 patent.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/13/2009 | 7/24/2012 | Spectroscopy, Nuclear magnetic resonance, Magnetic resonance imaging, Medical physics, Medical equipment | Grant |
Application Date | 10/13/2009 |
|---|---|
Grant Date | 7/24/2012 |
Title | |
Related Topics | Spectroscopy, Nuclear magnetic resonance, Magnetic resonance imaging, Medical physics, Medical equipment |
Status | Grant |
BMDSys Frequently Asked Questions (FAQ)
When was BMDSys founded?
BMDSys was founded in 2005.
What is BMDSys's latest funding round?
BMDSys's latest funding round is Other Investors.
Who are the investors of BMDSys?
Investors of BMDSys include National Technology Enterprises Corporation, Wellington Partners, Kuwait National Technology Enterprises Corporation and IBG Beteiligungsgesellschaft.
Who are BMDSys's competitors?
Competitors of BMDSys include iMMCO Diagnostics, Imagimed, Insight Imaging, Cardiac Science Corporation, Neuronetics and 13 more.
Compare BMDSys to Competitors
PetsDx Veterinary Imaging, Inc. is engaged in veterinary medicine and magnetic resonance imaging (MRI). PetsDX works with local veterinarians.
Cellatope is a cell analysis company that is developing research and diagnostic products and services in the field of autoimmune and inflammatory disease, with an initial focus on lupus and transplant medicine.
Celsense is a biotechnology company offering MRI agents that allow scientists and clinicians to monitor the location and quantity of transplanted cells. The company's products have application in the fields of regenerative medicine, immunotherapy, and the study of inflammation and immune system response. Celsense is currently collaborating with pharmaceutical and biotechnology organizations and is developing products suitable for human use.
Imagimed is a provider of diagnostic imaging services with thirteen freestanding, outpatient magnetic resonance imaging ("MRI") facilities in Maryland, Pennsylvania, and New York.
EXCMR develops medical devices to enhance cardiovascular magnetic resonance imaging (MRI). The company has developed an MRI-compatible treadmill that aims to allow cardiovascular exercise stress testing with MRI, giving doctors pictures of the heart immediately following peak exercise stress. MRI shows both heart function and perfusion (blood flow to the heart muscle) with higher resolution and clarity than available with other imaging tests. Symptoms, like chest pain, caused by coronary artery blockages often can be reproduced only with exercise-induced stress. Images of the heart taken immediately after exercise allow doctors to examine the pumping action and blood flow at rest and stress to more accurately determine the cause of symptoms. The MRI-compatible treadmill aims to allow for the first time the combination of exercise stress testing with magnetic resonance imaging. EXCMR was specifically formed to provide commercial production and distribution of the treadmill.
Neurognostics is engaged in the commercialization of functional Magnetic Resonance Imaging (fMRI) technologies for early diagnosis of central nervous system (CNS) disorders and support of new pharmaceutical therapeutic development.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.